SeaSpine Holdings Corporation logo
SeaSpine Holdings Corporation SPNE
report update icon

Quarterly report 2022-Q3
added 05-30-2026

SeaSpine Holdings Corporation Balance Sheet 2021-2011 | SPNE

Brief overview of SeaSpine Holdings Corporation's financial position

The review uses the five latest available annual reports between 2017 and 2021.

Assets advanced +180.6% to $377.3 million from $134.5 million; annual growth near 29.4% reflects a fast increase in scale.

Liabilities increased less than assets, posting +125.2% versus +180.6%. That relationship usually strengthens the balance sheet.

Equity accounts for 82.8% of assets. Against the initial 78.6%, the capital position looks resilient.

Cash exceeds interest-bearing debt, producing net debt of -$75 million. The balance sheet therefore carries a net cash position.

Cash represents 22% of assets versus 8% initially, showing how the immediate liquidity reserve changed.

The balance sheet includes a negative accumulated result of -$273.6 million. It should be assessed alongside historical profits and capital distributions.

Overall assessment

SeaSpine Holdings Corporation has a solid balance sheet cushion. Capital and liquidity support development without excessive reliance on debt.

Annual Balance Sheet SeaSpine Holdings Corporation

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-75 M -69.6 M -20.2 M -24.2 M -10.8 M -10.7 M -33.1 M -652 K -646 K - -

Long Term Debt

5.87 M 5.06 M - - - 3.84 M 328 K - - - -

Long Term Debt Current

2.23 M 2.15 M - - - - - - - - -

Total Non Current Liabilities

- 12 M 1.48 M 3.71 M 5.66 M 11.8 M 3.02 M 2.41 M 3.56 M - -

Total Current Liabilities

53 M 30.7 M 30.5 M 26.5 M 23.2 M 24.4 M 26 M 46 M - - -

Total Liabilities

64.9 M 42.7 M 32 M 30.3 M 28.8 M 36.2 M 29 M 48.4 M 42 M - -

Deferred Revenue

1.54 M 102 K - - - - - - - - -

Retained Earnings

-274 M -219 M -176 M -137 M -103 M -71.2 M -27.9 M - - - -

Total Assets

377 M 214 M 142 M 172 M 134 M 147 M 176 M 140 M 153 M - -

Cash and Cash Equivalents

83.1 M 76.8 M 20.2 M 24.2 M 10.8 M 14.6 M 33.4 M 652 K 646 K - -

Book Value

312 M 172 M 110 M 142 M 106 M 111 M 147 M 91.3 M 111 M - -

Total Shareholders Equity

312 M 172 M 110 M 142 M 106 M 111 M 147 M 91.3 M 111 M - -

All numbers in USD currency

Quarterly Balance Sheet SeaSpine Holdings Corporation

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

- 15.1 M 15.5 M 5.4 M 5.87 M - - 24.8 M 5.06 M 7.23 M 7.55 M 7.96 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

- 99.7 M 98.7 M 83.6 M 64.9 M 63.2 M 59.1 M 71.1 M 42.7 M 43.2 M 46 M 37.8 M 32 M 33.8 M 33 M 31.5 M 30.3 M 38.2 M 32.9 M 26.5 M 28.8 M 29.7 M 36.5 M 33 M 36.2 M 40.1 M 27.8 M 26.3 M 29 M 27.3 M 29 M 29 M 48.4 M 48.4 M 48.4 M - - - - - - - - - - - - -

Deferred Revenue

- 2.14 M 2.26 M 2.37 M 1.54 M 1.35 M - - 102 K 102 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

- -320 M -304 M -290 M -274 M -255 M -237 M -232 M -219 M -209 M -202 M -189 M -176 M -167 M -158 M -146 M -137 M -127 M -118 M -110 M -103 M -95.8 M -88.3 M -80.3 M -71.2 M -61.4 M -51.9 M -40 M -27.9 M -14.2 M -27.9 M -27.9 M - - - - - - - - - - - - - - - -

Total Assets

- 374 M 386 M 380 M 377 M 390 M 397 M 230 M 214 M 222 M 226 M 228 M 142 M 150 M 157 M 165 M 172 M 132 M 135 M 134 M 134 M 141 M 142 M 140 M 147 M 160 M 155 M 164 M 176 M 186 M 176 M 176 M 140 M 140 M 140 M - - - - - - - - - - - - -

Cash and Cash Equivalents

- 102 M 121 M 87.7 M 83.1 M 102 M 121 M 87.7 M 76.8 M 78.2 M 75.3 M 80 M 20.2 M 22.3 M 21.5 M 20.1 M 24.2 M 11.8 M 13.3 M 12.5 M 10.8 M 16.7 M 12.3 M 12.7 M 14.6 M 20.8 M 23 M 28.6 M 33.4 M 38.5 M 33.4 M 33.4 M 652 K 652 K 652 K - 646 K - - - 91 K - - - - - - -

Book Value

- 274 M 287 M 297 M 312 M 327 M 338 M 159 M 172 M 179 M 180 M 190 M 110 M 116 M 124 M 133 M 142 M 94.2 M 102 M 108 M 106 M 111 M 105 M 107 M 111 M 120 M 127 M 137 M 147 M 159 M 147 M 147 M 91.3 M 91.3 M 91.3 M - - - - - - - - - - - - -

Total Shareholders Equity

- 274 M 287 M 297 M 312 M 327 M 338 M 159 M 172 M 179 M 180 M 190 M 110 M 116 M 124 M 133 M 142 M 94.2 M 102 M 108 M 106 M 111 M 105 M 107 M 111 M 120 M 127 M 137 M 147 M 159 M 147 M 147 M 91.3 M 91.3 M 91.3 M - 111 M - - - -5.62 M - - - - - - -

All numbers in USD currency

Balance Sheet is a fundamental financial report of SeaSpine Holdings Corporation, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.

For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.

Features of balance sheet analysis
  • Vertical and horizontal analysis
    Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods.
  • Asset quality
    It is important to evaluate not only the amount of assets but also their liquidity and realizability.
  • Accounting for off-balance sheet liabilities
    Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.

Balance sheet of other industry stocks – Medical devices

Issuer Price % 24h Market Cap Country
Sintx Technologies Sintx Technologies
SINT
$ 1.74 6.75 % $ 4.83 M usaUSA
Smith & Nephew plc Smith & Nephew plc
SNN
$ 27.87 0.16 % $ 24.2 B britainBritain
Stryker Corporation Stryker Corporation
SYK
$ 276.43 0.68 % $ 106 B usaUSA
Tandem Diabetes Care Tandem Diabetes Care
TNDM
$ 19.88 0.4 % $ 1.35 B usaUSA
Sensus Healthcare Sensus Healthcare
SRTS
$ 3.16 0.94 % $ 51.6 M usaUSA
Viemed Healthcare Viemed Healthcare
VMD
$ 8.79 0.78 % $ 342 M usaUSA
Varex Imaging Corporation Varex Imaging Corporation
VREX
$ 18.49 0.03 % $ 765 M usaUSA
NuVasive NuVasive
NUVA
- - $ 2.07 B usaUSA
Vivos Therapeutics Vivos Therapeutics
VVOS
$ 0.18 6.76 % $ 1.85 M usaUSA
TELA Bio TELA Bio
TELA
$ 0.83 1.05 % $ 39 M usaUSA
Beyond Air Beyond Air
XAIR
$ 3.38 0.93 % $ 28.1 B usaUSA
Zimmer Biomet Holdings Zimmer Biomet Holdings
ZBH
$ 94.22 0.69 % $ 18.7 B usaUSA
Cognyte Software Ltd. Cognyte Software Ltd.
CGNT
$ 8.23 0.71 % $ 600 M israelIsrael
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
- - $ 3.31 B usaUSA
BIOLASE BIOLASE
BIOL
- -13.19 % $ 166 K usaUSA
Conformis Conformis
CFMS
- - $ 16.4 M usaUSA
Cutera Cutera
CUTR
- -10.19 % $ 1.99 M usaUSA
Eargo Eargo
EAR
- - $ 10.2 M usaUSA
Medigus Ltd. Medigus Ltd.
MDGS
- 10.28 % $ 55.5 M israelIsrael
Inari Medical Inari Medical
NARI
- - $ 4.23 B usaUSA
Nemaura Medical Nemaura Medical
NMRD
- -17.8 % $ 2.74 M britainBritain
Neovasc Neovasc
NVCN
- - $ 111 M canadaCanada
SmileDirectClub SmileDirectClub
SDC
- -53.45 % $ 9.71 M usaUSA
Sientra Sientra
SIEN
- -16.59 % $ 10.3 M usaUSA
Silk Road Medical, Inc Silk Road Medical, Inc
SILK
- - $ 1.07 B usaUSA
Surgalign Holdings Surgalign Holdings
SRGA
- -32.98 % $ 1.68 M usaUSA
ShockWave Medical ShockWave Medical
SWAV
- - $ 12.3 B usaUSA
ThermoGenesis Holdings ThermoGenesis Holdings
THMO
- -25.84 % $ 171 K usaUSA
Talis Biomedical Corporation Talis Biomedical Corporation
TLIS
- 3.55 % $ 7.96 M usaUSA
Viveve Medical Viveve Medical
VIVE
- -15.35 % $ 1.71 M usaUSA
ViewRay ViewRay
VRAY
- 1.54 % $ 468 M usaUSA
Titan Medical Titan Medical
TMDI
- -26.32 % $ 19.6 M canadaCanada
Natus Medical Incorporated Natus Medical Incorporated
NTUS
- 1.94 % $ 1.05 B usaUSA
Acutus Medical Acutus Medical
AFIB
- -26.83 % $ 2.62 M usaUSA
Cardiovascular Systems Cardiovascular Systems
CSII
- 0.15 % $ 844 M usaUSA
Invacare Corporation Invacare Corporation
IVC
- - $ 24.7 M usaUSA
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
- - $ 1.77 B usaUSA
Lianluo Smart Limited Lianluo Smart Limited
LLIT
- 24.59 % $ 44.8 M chinaChina
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
- -5.86 % $ 30.6 M usaUSA
Profound Medical Corp. Profound Medical Corp.
PROF
$ 6.81 1.32 % $ 206 M canadaCanada
Tactile Systems Technology Tactile Systems Technology
TCMD
$ 21.73 0.09 % $ 497 M usaUSA
Abbott Laboratories Abbott Laboratories
ABT
$ 105.52 0.03 % $ 184 B usaUSA
Aethlon Medical Aethlon Medical
AEMD
$ 1.81 1.09 % $ 1.22 M usaUSA
AdaptHealth Corp. AdaptHealth Corp.
AHCO
$ 6.19 1.09 % $ 837 M usaUSA
Align Technology Align Technology
ALGN
$ 153.49 0.03 % $ 11.1 B usaUSA
Apyx Medical Corporation Apyx Medical Corporation
APYX
$ 3.05 0.33 % $ 125 M usaUSA
Accuray Incorporated Accuray Incorporated
ARAY
$ 0.26 0.37 % $ 31.9 M usaUSA
Alphatec Holdings Alphatec Holdings
ATEC
$ 9.19 1.29 % $ 1.38 B usaUSA
AxoGen AxoGen
AXGN
$ 46.69 2.51 % $ 2.15 B usaUSA
Butterfly Network Butterfly Network
BFLY
$ 7.52 2.17 % $ 1.86 B usaUSA